SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000891293-17-000054
Filing Date
2017-05-03
Accepted
2017-05-03 17:07:34
Documents
48
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cti10q03312017.htm 10-Q 809338
2 EXHIBIT 10.1 ex101.htm EX-10.1 16546
3 EXHIBIT 10.4 ex104.htm EX-10.4 719417
4 EXHIBIT 31.1 ex311-cti10q03312017.htm EX-31.1 11002
5 EXHIBIT 31.2 ex312-cti10q03312017.htm EX-31.2 12165
6 EXHIBIT 32 ex32-cti10q03312017.htm EX-32 11926
  Complete submission text file 0000891293-17-000054.txt   3633714

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ctic-20170331.xml EX-101.INS 330578
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctic-20170331.xsd EX-101.SCH 24344
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctic-20170331_cal.xml EX-101.CAL 61481
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctic-20170331_def.xml EX-101.DEF 80154
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctic-20170331_lab.xml EX-101.LAB 348022
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctic-20170331_pre.xml EX-101.PRE 189389
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-28386 | Film No.: 17810329
SIC: 2834 Pharmaceutical Preparations